Ventyx Biosciences Inc (VTYX)
4.85
-0.06
(-1.22%)
USD |
NASDAQ |
May 03, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Ventyx Biosciences Shareholders Equity (Quarterly): 243.92M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 243.92M |
| September 30, 2023 | 283.64M |
| June 30, 2023 | 327.81M |
| March 31, 2023 | 371.62M |
| December 31, 2022 | 353.90M |
| September 30, 2022 | 383.53M |
| Date | Value |
|---|---|
| June 30, 2022 | 243.15M |
| March 31, 2022 | 259.12M |
| December 31, 2021 | 279.20M |
| September 30, 2021 | -87.62M |
| June 30, 2021 | -75.86M |
| December 31, 2020 | -30.65M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-87.62M
Minimum
Sep 2021
383.53M
Maximum
Sep 2022
212.65M
Average
269.16M
Median
Shareholders Equity (Quarterly) Benchmarks
| Anavex Life Sciences Corp | 135.58M |
| CERo Therapeutics Holdings Inc | -- |
| Avinger Inc | -6.202M |
| Checkpoint Therapeutics Inc | -13.05M |
| RAPT Therapeutics Inc | 147.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 277.69M |
| Total Liabilities (Quarterly) | 33.77M |